# Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy

> **NCT03837327** · — · COMPLETED · sponsor: **Venn Biosciences Corporation** · enrollment: 1025 (actual)

## Conditions studied

- Adnexal Mass
- Ovarian Cancer
- Pelvic Mass

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03837327
- **Lead sponsor:** Venn Biosciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-16
- **Primary completion:** 2024-01-22
- **Final completion:** 2024-01-22
- **Target enrollment:** 1025 (ACTUAL)
- **Last updated:** 2024-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03837327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03837327, "Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03837327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*